Peptinovo Biopharma is a pre-clinical biotechnology company, founded by two experienced biotech startup entrepreneurs who have successfully created and exited from previous biotech start-ups. 

Founder Ren Homan’s insights into pharmacology, gained over 35+ years of success at both big pharma and early-stage start-ups, led to the PALM innovation. Further, all phases necessary for a successful product launch (Chemical Manufacturing Control, FDA regulatory strategy and process, and non-clinical preclinical safety testing) are led by individuals who each have 30+ years of experience in drug development and commercial launch from preclinical testing through New Drug Application to Marketing Authorization Application.